PVH
ALXN

Psagot Value Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Psagot Value Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-110
Closed -$17K – 398
2020
Q4 		$17K Hold
110
– – ﹤0.01% 320
2020
Q3 		$13K Buy
+110
New +$11.9K ﹤0.01% 368
2018
Q2 		– Sell
-65
Closed -$7K – 381
2018
Q1 		$7K Buy
+65
New +$7.77K ﹤0.01% 320
2017
Q4 		– Sell
-173
Closed -$24K – 334
2017
Q3 		$24K Buy
+173
New +$23.5K ﹤0.01% 280
2016
Q2 		– Sell
-28
Closed -$4K – 403
2016
Q1 		$4K Hold
28
– – ﹤0.01% 357
2015
Q4 		$5K Hold
28
– – ﹤0.01% 366
2015
Q3 		$4K Hold
28
– – ﹤0.01% 357
2015
Q2 		$5K Hold
28
– – ﹤0.01% 362
2015
Q1 		$5K Buy
+28
New +$5.07K ﹤0.01% 345

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return